Dr. Keith Stewart and Dr. Meletios A. Dimopoulos discuss Kyprolis, results of the ASPIRE trial and key topics in multiple myeloma.

Learn more about a patient’s journey through multiple myeloma.

An inside look at the mechanism of action of proteasome inhibition.

Kyprolis EU Product Image

Multiple myeloma is characterized by the over production of antibodies (light blue, center) by plasma cells within the bone marrow, which interferes with healthy cell functions.

Kyrpolis Logo